Anondita Medicare Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Operating Revenue	769.91	464.32	359.15
Other Revenue	-	-0	-
Revenue	769.91	464.32	359.15
Revenue Growth (YoY)	65.81%	29.28%	-
Cost of Revenue	382.86	320.41	280.33
Gross Profit	387.05	143.92	78.82
Selling, General & Admin	94.04	18.69	15.46
Other Operating Expenses	35.26	33.89	26.52
Operating Expenses	138.57	59.14	48.24
Operating Income	248.48	84.78	30.59
Interest Expense	-27.58	-31.9	-24.6
Interest & Investment Income	0.41	1.14	0.98
Currency Exchange Gain (Loss)	-0.01	0.06	0.33
Other Non Operating Income (Expenses)	-1.69	-2.58	-2.62
EBT Excluding Unusual Items	219.62	51.5	4.68
Gain (Loss) on Sale of Assets	-0.09	-	-
Pretax Income	219.53	51.53	4.68
Income Tax Expense	55.37	13.08	1.21
Earnings From Continuing Operations	164.17	38.45	3.47
Minority Interest in Earnings	-6.23	-	-
Net Income	157.94	38.45	3.47
Preferred Dividends & Other Adjustments	6.23	-	-
Net Income to Common	151.71	38.45	3.47
Net Income Growth	310.80%	1008.30%	-
Shares Outstanding (Basic)	11	13	-
Shares Outstanding (Diluted)	11	13	-
Shares Change (YoY)	-15.35%	-	-
EPS (Basic)	13.48	2.89	-
EPS (Diluted)	13.48	2.89	-
EPS Growth	366.15%	-	-
Free Cash Flow	-174.75	65.06	-97.95
Free Cash Flow Per Share	-15.53	4.89	-
Gross Margin	50.27%	31.00%	21.95%
Operating Margin	32.27%	18.26%	8.52%
Profit Margin	19.71%	8.28%	0.97%
Free Cash Flow Margin	-22.70%	14.01%	-27.27%
EBITDA	257.75	91.34	36.84
EBITDA Margin	33.48%	19.67%	10.26%
D&A For EBITDA	9.27	6.57	6.26
EBIT	248.48	84.78	30.59
EBIT Margin	32.27%	18.26%	8.52%
Effective Tax Rate	25.22%	25.39%	25.81%
Revenue as Reported	771.3	465.55	361.4
Advertising Expenses	10.29	0.01	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.